MDT as reported
Medtronic reported $36.4B of revenue over the trailing twelve months, +8.4% on the year before. 11 reported series are charted on this page, each one as filed.
$36.4B
Revenue, trailing twelve months · to Q4 2026 · +8.4% against the twelve months before
- Net Income
- $4.80B
Net Income · +3.0% year on year · trailing twelve months to Q4 2026
- Free Cash Flow
- $5.43B
Free Cash Flow · +4.6% year on year · trailing twelve months to Q4 2026
- Op Margin
- 18%
Op Margin · trailing twelve months to Q4 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $36.4B | +8.4% | Q4 2026 |
| Net Income | $4.80B | +3.0% | Q4 2026 |
| EPS | $3.74 | +3.3% | Q4 2026 |
| Gross Margin | 65% | n/a | Q4 2026 |
| Op Margin | 18% | n/a | Q4 2026 |
| Net Margin | 13% | n/a | Q4 2026 |
| ROE | 9.7% | n/a | Q4 2026 |
| ROA | 5.1% | n/a | Q4 2026 |
| ROIC | 7.1% | n/a | Q4 2026 |
| Free Cash Flow | $5.43B | +4.6% | Q4 2026 |
| P/E | 24.6 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Medtronic (MDT) - Revenue & ProfitRevenue & ProfitMedtronic (MDT)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Devices
Ranks #11 of 35 by Smart Score